The lower bioavailability actually works in favor here, as the body receives the active compound more gradually throughout the day rather than in a single bolus that can overwhelm GLP-1 receptors in the gut
Moura FA, Scirica BM, Ruff CT
He was surprised, when he searched the medical literature, that this finding hadnt come out of the blue
Research into the compound's in vitro binding kinetics, receptor selectivity, and downstream signalling cascades continues to expand the understanding of multi-receptor incretin pharmacology
Moreover, epidemiological data have established a significant association between visceral obesity and the pathogenesis of primary hepatic malignancies [15]
The supplement does not contain any GLP-1 receptor agonists or synthetic hormones, which sets it apart from other products on the market